Global In Silico Clinical Trials Market Report 2022: Growing Demand for Clinical Trials That Are Cost-Effective, Time-Efficient, & Avoid Animal Cruelty Fueling Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global In Silico Clinical Trials Market, By Industry (Medical Devices v/s Pharmaceuticals), By Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases, Orthopedic, Dermatology, Others), By Region, Competition Forecast and Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. The Global in Silico Clinical Trials Market was valued to be USD2743.64 million in the year … [Read more…]

Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022

NEW YORK & LONDON & PARIS–(BUSINESS WIRE)–Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that Mr. Darren Lui, CEO and Executive Director of Aptorum Group will present both in-person and virtually at the H.C. Wainwright … [Read more…]

Henry Schein to Present at Two Investor Conferences in September

MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September: Morgan Stanley 20th Annual Global Healthcare Conference at the Grand Hyatt in New York on September 12, 2022, at 9:20 … [Read more…]

Alpha Cognition Announces Second Quarter 2022 Results and Provides Corporate Update

VANCOUVER, B.C.–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today reported financial results and provided a corporate update for the second quarter ended June 30, 2022. “The Company released … [Read more…]

Athersys Announces 1-for-25 Reverse Stock Split

CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today that it will be executing a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-25 after the close of trading on the Nasdaq Stock Market on Friday, August 26, 2022. Athersys … [Read more…]

Baxter to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:35 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be … [Read more…]

P3 Health Partners Nevada Joins Humana Medicare Advantage Network

Humana Medicare Advantage members will have access to P3 Nevada’s Primary Care Providers in Clark and Nye Counties HENDERSON, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that P3 Health Partners-Nevada, LLC (“P3 Nevada”) and Humana, a leading health and well-being company, have signed an … [Read more…]

Omnicell to Host Investor Day on September 20, 2022

SANTA CLARA, Calif.–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and adherence tools for health systems and pharmacies, today announced that it will host an Investor Day on September 20, 2022 at 1:00 p.m. Eastern Time. The Investor Day will provide an opportunity for investors and analysts to hear from members of … [Read more…]

Quince Therapeutics to Present at Upcoming Scientific Meetings

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$QNCX–Quince Therapeutics, Inc. (Nasdaq: QNCX), a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced that the company will present at a number of scientific meetings taking place in September 2022, including the 14th International Conference on Osteogenesis Imperfecta (OI 2022), The American Society for Bone and Mineral … [Read more…]

iA Commemorates 50 Years of Innovation with Launch of New Pharmacy Solutions at NACDS Total Store Expo

INDIANAPOLIS & JOHNSON CITY, N.Y.–(BUSINESS WIRE)–#NACDS–iA, a leading provider of pharmacy fulfillment and automation solutions, is celebrating 50 years of innovation at NACDS Total Store Expo. With a commitment to its heritage, iA’s mission has never wavered from streamlining operational processes through advancing technology. Today, iA continues to drive pharmacy industry innovations. From safe and … [Read more…]